Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Parkinson's Disease

Free Subscription Articles published in Neurosci Lett Retrieve available abstracts of 86 articles: HTML format Text format

Single Articles

March 2010
1. JIAMING M , Chaoshi N
   Alterations of Hrd1 expression in various encephalic regional neurons in 6-OHDA model of Parkinson's Disease.
   Neurosci Lett. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. FEI QZ , Cao L, Xiao Q, Zhang T, et al
   Lack of association between ATP13A2 Ala746Thr and Parkinson's disease in Han population of mainland China.
   Neurosci Lett. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
3. MARIA IS , Elena VF, Aleksey VK, Peter AS, et al
   Expression analysis of Suppression of Tumorigenicity 13 gene in patients with Parkinson's Disease.
   Neurosci Lett. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. COPPEDE F , Ceravolo R, Migheli F, Fanucchi F, et al
   The hOGG1 Ser326Cys polymorphism is not associated with sporadic Parkinson's disease.
   Neurosci Lett. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. TAKENOKUCHI M , Kadoyama K, Chiba S, Sumida M, et al
   SJLB mice develop tauopathy-induced parkinsonism.
   Neurosci Lett. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. WANG L , Guo JF, Zhang WW, Xu Q, et al
   Novel GIGYF2 gene variants in patients with Parkinson's disease in Chinese population.
   Neurosci Lett. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
7. BIALECKA M , Kurzawski M, Tan EK, Drozdzik M, et al
   Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson's disease in a Polish population, and a meta-analysis.
   Neurosci Lett. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. ORDONEZ-LIBRADO JL , Anaya-Martinez V, Gutierrez-Valdez AL, Montiel-Flores E, et al
   L-DOPA TREATMENT REVERSES THE MOTOR ALTERATIONS INDUCED BY MANGANESE EXPOSURE AS A PARKINSON DISEASE EXPERIMENTAL MODEL.
   Neurosci Lett. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. CRAMER SC , Sampat A, Haske-Palomino M, Nguyen S, et al
   Increased prevalence of val(66)met BDNF genotype among subjects with cervical dystonia.
   Neurosci Lett. 2010;468:42-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
10. RABIN E , Muratori L, Svokos K, Gordon A, et al
    Tactile/proprioceptive integration during arm localization is intact in individuals with Parkinson's disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. D'ANDREA G , Nordera G, Pizzolato G, Bolner A, et al
    Trace amine metabolism in Parkinson's disease: Low circulating levels of octopamine in early disease stages.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. MIKI Y , Tomiyama M, Ueno T, Haga R, et al
    Clinical availability of skin biopsy in the diagnosis of Parkinson's disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. MAO XY , Burgunder JM, Zhang ZJ, An XK, et al
    Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
14. NISHIOKA K , Vilarino-Guell C, Cobb SA, Kachergus JM, et al
    Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. GODEIRO-JUNIOR C , Aguiar PM, Felicio AC, Barsottini OG, et al
    PINK1 polymorphism IVS1 -7 A-->G, exposure to environmental risk factors and anticipation of disease onset in Brazilian patients with early-onset Parkinsons Disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. ISOBE C , Abe T, Terayama Y
    Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2'-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodege
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. HIGA M , Ohnuma T, Maeshima H, Hatano T, et al
    Association analysis between functional polymorphism of the rs4606 SNP in the RGS2 gene and antipsychotic-induced Parkinsonism in Japanese patients with schizophrenia:
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. GAWEDA-WALERYCH K , Safranow K, Maruszak A, Bialecka M, et al
    Mitochondrial transcription factor A variants and the risk of Parkinson's disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. DE BONIS ML , Tessitore A, Pellecchia MT, Longo K, et al
    Impaired transmethylation potential in Parkinson's disease patients treated with l-Dopa.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. MARTINEZ HR , Gonzalez-Gonzalez H, Cantu-Martinez L, Rangel-Guerra R, et al
    PARKIN-coding polymorphisms are not associated with Parkinson's disease in a population from northeastern Mexico.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
21. ORTIZ-ORTIZ MA , Moran JM, Ruiz-Mesa LM, Niso-Santano M, et al
    Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. DENG S , Deng H, Le W, Xu H, et al
    Genetic analysis of the NEUROG2 gene in patients with Parkinson's disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. WANG L , Guo JF, Nie LL, Xu Q, et al
    A novel LRRK2 mutation in a mainland Chinese patient with familial Parkinson's disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. SCALZO P , Kummer A, Cardoso F, Teixeira AL, et al
    Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. BLANDINI F , Balestra B, Levandis G, Cervio M, et al
    Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. TIMMONS S , Coakley MF, Moloney AM, O' Neill C, et al
    Akt signal transduction dysfunction in Parkinson's disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. SHOJAEE S , Fazlali Z, Ghazavi F, Banihosseini SS, et al
    Identification of four novel potentially Parkinson's disease associated LRRK2 variations among Iranian patients.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
28. KASAP M , Akpinar G, Sazci A, Idrisoglu HA, et al
    Evidence for the presence of full-length PARK2 mRNA and Parkin protein in human blood.
    Neurosci Lett. 2009;460:196-200.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. PAINE S , Bedford L, Thorpe JR, Mayer RJ, et al
    Immunoreactivity to Lys63-linked polyubiquitin is a feature of neurodegeneration.
    Neurosci Lett. 2009;460:205-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. SAITO Y , Hamakubo T, Yoshida Y, Ogawa Y, et al
    Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
31. ZHANG Y , Zheng L, Zhang T, Wang Y, et al
    GIGYF2 Asn56Ser mutation is rare in Chinese Parkinson's disease patients.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. FALK T , Zhang S, Sherman SJ
    Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease.
    Neurosci Lett. 2009;458:49-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. OGURO H , Ward R, Bracewel M, Hindle J, et al
    Automatic activation of motor programs by object affordances in patients with Parkinson's disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. NOVAK P , Klemp JA, Ridings LW, Lyons KE, et al
    Effect of deep brain stimulation of the subthalamic nucleus upon the contralateral subthalamic nucleus in Parkinson disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. NAGANO-SAITO A , Liu J, Doyon J, Dagher A, et al
    Dopamine modulates default mode network deactivation in elderly individuals during the Tower of London task.
    Neurosci Lett. 2009;458:1-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. FENG ZH , Ji MA, Li YU, Gang YU, et al
    Grafted neural stem cells migrate to substantia nigra and improve behavior in Parkinsonian rats.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
37. SLEIMAN PM , Healy DG, Muqit MM, Yang YX, et al
    Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.
    Neurosci Lett. 2009;457:75-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. FAN W , Ding H, Ma J, Chan P, et al
    Impulse Control Disorders in Parkinson's Disease in a Chinese Population.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. SOTIRIOU S , Gibney G, Baxevanis AD, Nussbaum RL, et al
    A single nucleotide polymorphism in the 3'UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. KEELING BH , Vilarino-Guell C, Ross OA, Wszolek ZK, et al
    DRD3 Ser9Gly and HS1BP3 Ala256Gly are not associated with Parkinson Disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. KALAITZAKIS ME , Pearce RK, Gentleman SM
    Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodies.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
42. TOMIYAMA H , Li Y, Yoshino H, Mizuno Y, et al
    Mutation analysis for DJ-1 in sporadic and familial parkinsonism: screening strategy in parkinsonism.
    Neurosci Lett. 2009;455:159-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. ZHANG JL , Yang JF, Chan P
    No association between polymorphism of serotonin transporter gene and depression in Parkinson's disease in Chinese.
    Neurosci Lett. 2009;455:155-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. WU T , Wang L, Chen Y, Zhao C, et al
    Changes of functional connectivity of the motor network in the resting state in Parkinson's disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. DAS G , Misra AK, Das SK, Ray K, et al
    Microtubule-Associated Protein Tau (MAPT) Influences the Risk of Parkinson's Disease Among Indians.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. CAUDLE WM , Kitsou E, Li J, Bradner J, et al
    A role for a novel protein, nucleolin, in Parkinson's disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. GUO Y , Jankovic J, Zhu S, Le W, et al
    GIGYF2 Asn56Ser and Asn457Thr mutations in Parkinson disease patients.
    Neurosci Lett. 2009;454:209-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. YANG F , Yang YP, Mao CJ, Cao BY, et al
    Role of autophagy and proteasome degradation pathways in apoptosis of PC12 cells overexpressing human alpha-synuclein.
    Neurosci Lett. 2009;454:203-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. SETHI P , Lukiw WJ
    Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
50. RAJASANKAR S , Manivasagam T, Surendran S
    Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's disease.
    Neurosci Lett. 2009;454:11-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. FU Y , Ito M, Fujita Y, Ito M, et al
    Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.
    Neurosci Lett. 2009;453:81-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. SILVEIRA-MORIYAMA L , Holton JL, Kingsbury A, Ayling H, et al
    Regional differences in the severity of Lewy body pathology across the olfactory cortex.
    Neurosci Lett. 2009;453:77-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
53. WIDER C , Lincoln SJ, Heckman MG, Diehl NN, et al
    Phactr2 and Parkinson's disease.
    Neurosci Lett. 2009;453:9-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. GATTA L , Cardinale A, Wannenes F, Consoli C, et al
    Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs.
    Neurosci Lett. 2009;453:36-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. CAETANO MJ , Gobbi LT, Sanchez-Arias Mdel R, Stella F, et al
    Effects of postural threat on walking features of Parkinson's disease patients.
    Neurosci Lett. 2009;452:136-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. KALINDERI K , Bostantjopoulou S, Paisan-Ruiz C, Katsarou Z, et al
    Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece.
    Neurosci Lett. 2009;452:87-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. SCALZO PL , Ikuta N, Cardoso F, Regner A, et al
    Quantitative plasma DNA analysis in Parkinson's disease.
    Neurosci Lett. 2009;452:5-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
58. LIM JH , Kim SS, Boo DH, No H, et al
    Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes.
    Neurosci Lett. 2009;451:185-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. OHRFELT A , Grognet P, Andreasen N, Wallin A, et al
    Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Neurosci Lett. 2009;450:332-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
60. AHN KH , Kim YS, Kim SY, Huh Y, et al
    Okadaic acid protects human neuroblastoma SH-SY5Y cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis.
    Neurosci Lett. 2009;449:93-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. BLACKINTON J , Kumaran R, van der Brug MP, Ahmad R, et al
    Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease.
    Neurosci Lett. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
62. LIU J , Wang YY, Liu L, Wang QD, et al
    Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Neurosci Lett. 2008;448:184-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
63. CHOI YG , Park JH, Lim S
    Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced parkinsonism model.
    Neurosci Lett. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. YANG JF , Wu T, Li JY, Li YJ, et al
    DYT1 mutations in early onset primary torsion dystonia and Parkinson disease patients in Chinese populations.
    Neurosci Lett. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. NAGAO M , Hayashi H
    Glycogen synthase kinase-3beta is associated with Parkinson's disease.
    Neurosci Lett. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
66. WANG XP , Sun BM, Ding HL
    Changes of procedural learning in Chinese patients with non-demented Parkinson disease.
    Neurosci Lett. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. RODRIGUES JP , Walters SE, Stell R, Mastaglia FL, et al
    Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: Evidence from transcranial magnetic stimulation.
    Neurosci Lett. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. XANTHOPOULOS P , Heilman KM, Drago V, Pardalos P, et al
    An ambulatory persistence power curve: Motor planning affects ambulatory persistence in Parkinson's disease.
    Neurosci Lett. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. EZQUERRA M , Campdelacreu J, Gaig C, Compta Y, et al
    Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease.
    Neurosci Lett. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
70. HARGREAVES IP , Lane A, Sleiman PM
    The coenzyme Q(10) status of the brain regions of Parkinson's disease patients.
    Neurosci Lett. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. BOHNEN NI , Gedela S, Herath P, Constantine GM, et al
    Selective hyposmia in Parkinson disease: Association with hippocampal dopamine activity.
    Neurosci Lett. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
72. ZHOU YT , Yang JF, Zhang YL, Wang XY, et al
    Protective role of interlekin-1 alpha gene polymorphism in Chinese Han population with sporadic Parkinson's disease.
    Neurosci Lett. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
73. MORRISON S , Kerr G, Newell KM, Silburn PA, et al
    Differential time- and frequency-dependent structure of postural sway and finger tremor in Parkinson's disease.
    Neurosci Lett. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. AMTAGE F , Henschel K, Schelter B, Vesper J, et al
    Tremor-correlated neuronal activity in the subthalamic nucleus of Parkinsonian patients.
    Neurosci Lett. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. ZHANG ZJ , Burgunder JM, An XK, Wu Y, et al
    Lack of evidence for association of a UCH-L1 S18Y polymorphism with Parkinson's disease in a Han-Chinese population.
    Neurosci Lett. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
76. BRODACKI B , Staszewski J, Toczylowska B, Kozlowska E, et al
    Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism.
    Neurosci Lett. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. LI T , Ho YS, Li CY
    Bibliometric analysis on global Parkinson's disease research trends during 1991-2006.
    Neurosci Lett. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. CAMICIOLI RM , Wieler M, de Frias CM, Martin WR, et al
    Early, untreated Parkinson's disease patients show reaction time variability.
    Neurosci Lett. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
79. LOCKE CJ , Fox SA, Caldwell GA, Caldwell KA, et al
    Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.
    Neurosci Lett. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
80. ALERTE TN , Akinfolarin AA, Friedrich EE, Mader SA, et al
    Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.
    Neurosci Lett. 2008;435:24-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
81. XIROMERISIOU G , Hadjigeorgiou GM, Papadimitriou A, Katsarogiannis E, et al
    Association between AKT1 gene and Parkinson's disease: A protective haplotype.
    Neurosci Lett. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
82. CHEN CM , Wu YR, Hu FJ, Chen YC, et al
    HSPA5 promoter polymorphisms and risk of Parkinson's disease in Taiwan.
    Neurosci Lett. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
83. TAKATORI S , Ito G, Iwatsubo T
    Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1.
    Neurosci Lett. 2008;430:13-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2007
84. PIMENTEL MM , Moura KC, Abdalla CB, Pereira JS, et al
    A study of LRRK2 mutations and Parkinson's disease in Brazil.
    Neurosci Lett. 2007;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. NAKASO K , Ito S, Nakashima K
    Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.
    Neurosci Lett. 2007;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. ALVAREZ V , Corao AI, Sanchez-Ferrero E, De Mena L, et al
    Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.
    Neurosci Lett. 2007;.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: